Back to LOS ANGELES CAPITAL MANAGEMENT LLC LOS ANGELES CAPITAL MANAGEMENT LLC

IBRXIBRX
Showing 3 of 6 quarters

Position history for LOS ANGELES CAPITAL MANAGEMENT LLCLOS ANGELES CAPITAL MANAGEMENT LLC's holdings in IMMUNITYBIO INC

LOS ANGELES CAPITAL MANAGEMENT LLC holds 3,550 shares of IBRX (IMMUNITYBIO INC), worth $31,080 as of 2026-Q2. The position was increased (+7.8% shares). IBRX represents 0.0% of LOS ANGELES CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$31,080

Current Shares

3,550

Total Value Change

-$281,027

Total Shares Change

-128,698

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3,550
+7.8%
$31,0800.0%$8.76
21
2026-Q1
Decreased
3,292
-97.5%
$25,2500.0%$10.00
0
2025-Q4
New
132,248
-
$312,1070.0%$1.98
32

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used